Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B
Alimentary Pharmacology and Therapeutics,  Clinical Article

Ghany MG et al. – Extended combination therapy with lamivudine and adefovir is associated with a high rate of long–term virological and biochemical response. Adefovir monotherapy appears to be less effective mainly because of poor initial response and the ultimate development of antiviral resistance.

Methods
  • Patients with chronic hepatitis B with and without previous lamivudine therapy were randomised to receive adefovir alone (10 mg/daily) or adefovir and lamivudine (100 mg/daily) for up to 192 weeks.
  • Study endpoints were :
    • Maintained virological (HBV DNA <500 copies/mL), biochemical and histological response
    • Loss of HBeAg
    • Loss of HBsAg.

Results
  • A total of 41 patients were enrolled, including 31 HBeAg -positive and 31 treatment-naive subjects.
  • 30 patients remained on assigned therapy at 192 weeks.
  • The percentage of patients achieving a combined maintained response was higher in the combination than the monotherapy arm, both at week 48 (59% vs. 26%, P = 0.06) and 192 (68% vs. 31%, P = 0.03).
  • At week 192, 76% of the combination vs. 36% of the monotherapy group had loss of HBeAg (P = 0.03).
  • One patient receiving adefovir cleared HBsAg.
  • Adefovir resistance developed in 6 of 19 (32%) monotherapy but none of 22 combination treated patients (P = 0.03).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Infectious Disease

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Infectious Disease Articles

1 Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: A meta-analysis International Journal of Antimicrobial Agents, April 25, 2014    Review Article

2 Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States Clinical Infectious Diseases, July 2, 2014    Clinical Article

3 HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial The Journal of Infectious Diseases, July 8, 2014    Clinical Article

4 Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America Clinical Infectious Diseases, June 20, 2014    Clinical Article

5 Vertical transmission of hepatitis C virus: Systematic review and meta-analysis Clinical Infectious Diseases, July 24, 2014    Evidence Based Medicine    Review Article

6 Infectious causes of stroke The Lancet Infectious Diseases, May 30, 2014    Clinical Article

7 Safety of vaccines used for routine immunization of US children: A systematic review Pediatrics, July 11, 2014    Clinical Article

8 High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: A comparative study Diagnostic Microbiology and Infectious Disease, June 9, 2014    Clinical Article

9 The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: A systematic review and exploratory meta-analysis The Journal of Infectious Diseases, July 23, 2014    Clinical Article

10 Statins use and risk of mortality in patient with Clostridium difficile infection Clinical Microbiology and Infection, May 12, 2014    Clinical Article

11 Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: A phase I/II, randomized trial AIDS, July 14, 2014    Clinical Article

12 Breastfeeding and HIV-infected women in the United States: Harm reduction counseling strategies Clinical Infectious Diseases, July 1, 2014    Review Article

13 Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection Journal of Viral Hepatitis, July 14, 2014    Clinical Article

14 The return of the big three killers Clinical Microbiology and Infection, July 30, 2013    Clinical Article

15 Ethanol versus heparin locks for the prevention of central venous catheter-associated bloodstream infections: A randomized trial in adult haematology patients with Hickman devices Journal of Hospital Infection, July 10, 2014    Clinical Article

16 The efficacy of daptomycin versus vancomycin for methicillin-resistant staphylococcus aureus bloodstream infection in patients with impaired renal function Clinical Infectious Diseases, April 21, 2014    Clinical Article

17 Sofosbuvir and ribavirin for hepatitis c in patients with hiv coinfection JAMA, July 30, 2014    Evidence Based Medicine    Clinical Article

18 Cancer treatment disparities in HIV-infected individuals in the United States Journal of Clinical Oncology, July 22, 2014    Clinical Article

19 Prevalence and risk factors for asymptomatic clostridium difficile carriage Clinical Infectious Diseases, July 2, 2014    Clinical Article

20 Association between chronic hepatitis C virus infection and low muscle mass in US adults Journal of Viral Hepatitis, July 3, 2014    Clinical Article

Indexed Journals in Infectious Disease: Journal of Infection, AIDS, American Journal of Infection Controlmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close